nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—Risedronate—osteoporosis	0.184	0.306	CbGbCtD
Etoricoxib—CYP1A2—Estropipate—osteoporosis	0.0525	0.0874	CbGbCtD
Etoricoxib—CYP2C9—Estropipate—osteoporosis	0.0473	0.0787	CbGbCtD
Etoricoxib—CYP2C19—Cholecalciferol—osteoporosis	0.0293	0.0488	CbGbCtD
Etoricoxib—CYP3A4—Estropipate—osteoporosis	0.0275	0.0458	CbGbCtD
Etoricoxib—CYP3A4—Calcitriol—osteoporosis	0.0275	0.0458	CbGbCtD
Etoricoxib—CYP1A2—Conjugated Estrogens—osteoporosis	0.0248	0.0413	CbGbCtD
Etoricoxib—CYP2C9—Cholecalciferol—osteoporosis	0.0244	0.0406	CbGbCtD
Etoricoxib—CYP2C19—Estradiol—osteoporosis	0.0236	0.0393	CbGbCtD
Etoricoxib—CYP2D6—Cholecalciferol—osteoporosis	0.0223	0.0371	CbGbCtD
Etoricoxib—CYP3A4—Ergocalciferol—osteoporosis	0.022	0.0366	CbGbCtD
Etoricoxib—CYP1A2—Estradiol—osteoporosis	0.0218	0.0363	CbGbCtD
Etoricoxib—CYP2C9—Estradiol—osteoporosis	0.0196	0.0327	CbGbCtD
Etoricoxib—CYP3A4—Raloxifene—osteoporosis	0.0183	0.0305	CbGbCtD
Etoricoxib—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0177	0.0295	CbGbCtD
Etoricoxib—CYP3A4—Cholecalciferol—osteoporosis	0.0142	0.0236	CbGbCtD
Etoricoxib—CYP3A4—Conjugated Estrogens—osteoporosis	0.013	0.0216	CbGbCtD
Etoricoxib—CYP3A4—Estradiol—osteoporosis	0.0114	0.019	CbGbCtD
Etoricoxib—Celecoxib—CA2—osteoporosis	0.00334	1	CrCbGaD
Etoricoxib—Urinary tract disorder—Estradiol—osteoporosis	0.000169	0.000578	CcSEcCtD
Etoricoxib—Vomiting—Etidronic acid—osteoporosis	0.000169	0.000578	CcSEcCtD
Etoricoxib—Cough—Zoledronate—osteoporosis	0.000169	0.000577	CcSEcCtD
Etoricoxib—Oedema peripheral—Estradiol—osteoporosis	0.000169	0.000577	CcSEcCtD
Etoricoxib—Connective tissue disorder—Estradiol—osteoporosis	0.000168	0.000576	CcSEcCtD
Etoricoxib—Urethral disorder—Estradiol—osteoporosis	0.000168	0.000574	CcSEcCtD
Etoricoxib—Rash—Etidronic acid—osteoporosis	0.000168	0.000573	CcSEcCtD
Etoricoxib—Dermatitis—Etidronic acid—osteoporosis	0.000168	0.000573	CcSEcCtD
Etoricoxib—Hypertension—Zoledronate—osteoporosis	0.000167	0.000571	CcSEcCtD
Etoricoxib—Hypersensitivity—Alendronate—osteoporosis	0.000167	0.000571	CcSEcCtD
Etoricoxib—Headache—Etidronic acid—osteoporosis	0.000167	0.00057	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000166	0.000567	CcSEcCtD
Etoricoxib—Asthenia—Estropipate—osteoporosis	0.000165	0.000565	CcSEcCtD
Etoricoxib—Visual impairment—Estradiol—osteoporosis	0.000165	0.000564	CcSEcCtD
Etoricoxib—Anorexia—Pamidronate—osteoporosis	0.000165	0.000563	CcSEcCtD
Etoricoxib—Chest pain—Zoledronate—osteoporosis	0.000165	0.000563	CcSEcCtD
Etoricoxib—Arthralgia—Zoledronate—osteoporosis	0.000165	0.000563	CcSEcCtD
Etoricoxib—Palpitations—Conjugated Estrogens—osteoporosis	0.000165	0.000563	CcSEcCtD
Etoricoxib—Insomnia—Risedronate—osteoporosis	0.000164	0.000562	CcSEcCtD
Etoricoxib—Anxiety—Zoledronate—osteoporosis	0.000164	0.000561	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000164	0.000559	CcSEcCtD
Etoricoxib—Pruritus—Estropipate—osteoporosis	0.000163	0.000557	CcSEcCtD
Etoricoxib—Asthenia—Alendronate—osteoporosis	0.000163	0.000556	CcSEcCtD
Etoricoxib—Hypersensitivity—Ibandronate—osteoporosis	0.000163	0.000556	CcSEcCtD
Etoricoxib—Cough—Conjugated Estrogens—osteoporosis	0.000163	0.000556	CcSEcCtD
Etoricoxib—Dyspnoea—Risedronate—osteoporosis	0.000162	0.000554	CcSEcCtD
Etoricoxib—Erythema multiforme—Estradiol—osteoporosis	0.000162	0.000554	CcSEcCtD
Etoricoxib—Dry mouth—Zoledronate—osteoporosis	0.000161	0.000551	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000161	0.000551	CcSEcCtD
Etoricoxib—Fatigue—Ethinyl Estradiol—osteoporosis	0.000161	0.00055	CcSEcCtD
Etoricoxib—Pruritus—Alendronate—osteoporosis	0.00016	0.000548	CcSEcCtD
Etoricoxib—Dyspepsia—Risedronate—osteoporosis	0.00016	0.000547	CcSEcCtD
Etoricoxib—Eye disorder—Estradiol—osteoporosis	0.00016	0.000547	CcSEcCtD
Etoricoxib—Tinnitus—Estradiol—osteoporosis	0.00016	0.000546	CcSEcCtD
Etoricoxib—Constipation—Ethinyl Estradiol—osteoporosis	0.00016	0.000545	CcSEcCtD
Etoricoxib—Confusional state—Zoledronate—osteoporosis	0.000159	0.000544	CcSEcCtD
Etoricoxib—Hypersensitivity—Calcitriol—osteoporosis	0.000159	0.000544	CcSEcCtD
Etoricoxib—Cardiac disorder—Estradiol—osteoporosis	0.000159	0.000544	CcSEcCtD
Etoricoxib—Flushing—Estradiol—osteoporosis	0.000159	0.000544	CcSEcCtD
Etoricoxib—Arthralgia—Conjugated Estrogens—osteoporosis	0.000159	0.000542	CcSEcCtD
Etoricoxib—Chest pain—Conjugated Estrogens—osteoporosis	0.000159	0.000542	CcSEcCtD
Etoricoxib—Asthenia—Ibandronate—osteoporosis	0.000158	0.000541	CcSEcCtD
Etoricoxib—Anxiety—Conjugated Estrogens—osteoporosis	0.000158	0.00054	CcSEcCtD
Etoricoxib—Nausea—Etidronic acid—osteoporosis	0.000158	0.00054	CcSEcCtD
Etoricoxib—Anaphylactic shock—Zoledronate—osteoporosis	0.000158	0.00054	CcSEcCtD
Etoricoxib—Oedema—Zoledronate—osteoporosis	0.000158	0.00054	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000158	0.000539	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000158	0.000539	CcSEcCtD
Etoricoxib—Diarrhoea—Estropipate—osteoporosis	0.000157	0.000538	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Risedronate—osteoporosis	0.000157	0.000537	CcSEcCtD
Etoricoxib—Infection—Zoledronate—osteoporosis	0.000157	0.000536	CcSEcCtD
Etoricoxib—Fatigue—Risedronate—osteoporosis	0.000157	0.000536	CcSEcCtD
Etoricoxib—Insomnia—Pamidronate—osteoporosis	0.000156	0.000535	CcSEcCtD
Etoricoxib—Pruritus—Ibandronate—osteoporosis	0.000156	0.000534	CcSEcCtD
Etoricoxib—Pain—Risedronate—osteoporosis	0.000156	0.000532	CcSEcCtD
Etoricoxib—Constipation—Risedronate—osteoporosis	0.000156	0.000532	CcSEcCtD
Etoricoxib—Angiopathy—Estradiol—osteoporosis	0.000155	0.000531	CcSEcCtD
Etoricoxib—Shock—Zoledronate—osteoporosis	0.000155	0.000531	CcSEcCtD
Etoricoxib—Diarrhoea—Alendronate—osteoporosis	0.000155	0.00053	CcSEcCtD
Etoricoxib—Asthenia—Calcitriol—osteoporosis	0.000155	0.00053	CcSEcCtD
Etoricoxib—Nervous system disorder—Zoledronate—osteoporosis	0.000155	0.00053	CcSEcCtD
Etoricoxib—Immune system disorder—Estradiol—osteoporosis	0.000155	0.000529	CcSEcCtD
Etoricoxib—Thrombocytopenia—Zoledronate—osteoporosis	0.000155	0.000529	CcSEcCtD
Etoricoxib—Mediastinal disorder—Estradiol—osteoporosis	0.000154	0.000528	CcSEcCtD
Etoricoxib—Dyspnoea—Pamidronate—osteoporosis	0.000154	0.000527	CcSEcCtD
Etoricoxib—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000154	0.000526	CcSEcCtD
Etoricoxib—Somnolence—Pamidronate—osteoporosis	0.000154	0.000526	CcSEcCtD
Etoricoxib—Skin disorder—Zoledronate—osteoporosis	0.000153	0.000524	CcSEcCtD
Etoricoxib—Pruritus—Calcitriol—osteoporosis	0.000153	0.000523	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000153	0.000522	CcSEcCtD
Etoricoxib—Diarrhoea—Raloxifene—osteoporosis	0.000153	0.000521	CcSEcCtD
Etoricoxib—Dyspepsia—Pamidronate—osteoporosis	0.000152	0.00052	CcSEcCtD
Etoricoxib—Dizziness—Estropipate—osteoporosis	0.000152	0.00052	CcSEcCtD
Etoricoxib—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000152	0.00052	CcSEcCtD
Etoricoxib—Oedema—Conjugated Estrogens—osteoporosis	0.000152	0.00052	CcSEcCtD
Etoricoxib—Alopecia—Estradiol—osteoporosis	0.000151	0.000518	CcSEcCtD
Etoricoxib—Infection—Conjugated Estrogens—osteoporosis	0.000151	0.000517	CcSEcCtD
Etoricoxib—Diarrhoea—Ibandronate—osteoporosis	0.000151	0.000516	CcSEcCtD
Etoricoxib—Anorexia—Zoledronate—osteoporosis	0.000151	0.000515	CcSEcCtD
Etoricoxib—Decreased appetite—Pamidronate—osteoporosis	0.00015	0.000514	CcSEcCtD
Etoricoxib—Mental disorder—Estradiol—osteoporosis	0.00015	0.000513	CcSEcCtD
Etoricoxib—Dizziness—Alendronate—osteoporosis	0.00015	0.000512	CcSEcCtD
Etoricoxib—Shock—Conjugated Estrogens—osteoporosis	0.00015	0.000512	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000149	0.00051	CcSEcCtD
Etoricoxib—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000149	0.00051	CcSEcCtD
Etoricoxib—Erythema—Estradiol—osteoporosis	0.000149	0.00051	CcSEcCtD
Etoricoxib—Malnutrition—Estradiol—osteoporosis	0.000149	0.00051	CcSEcCtD
Etoricoxib—Fatigue—Pamidronate—osteoporosis	0.000149	0.00051	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Risedronate—osteoporosis	0.000149	0.000508	CcSEcCtD
Etoricoxib—Urticaria—Ethinyl Estradiol—osteoporosis	0.000148	0.000507	CcSEcCtD
Etoricoxib—Constipation—Pamidronate—osteoporosis	0.000148	0.000505	CcSEcCtD
Etoricoxib—Pain—Pamidronate—osteoporosis	0.000148	0.000505	CcSEcCtD
Etoricoxib—Diarrhoea—Calcitriol—osteoporosis	0.000148	0.000505	CcSEcCtD
Etoricoxib—Skin disorder—Conjugated Estrogens—osteoporosis	0.000148	0.000505	CcSEcCtD
Etoricoxib—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000147	0.000504	CcSEcCtD
Etoricoxib—Dizziness—Raloxifene—osteoporosis	0.000147	0.000504	CcSEcCtD
Etoricoxib—Flatulence—Estradiol—osteoporosis	0.000147	0.000502	CcSEcCtD
Etoricoxib—Vomiting—Estropipate—osteoporosis	0.000146	0.0005	CcSEcCtD
Etoricoxib—Dysgeusia—Estradiol—osteoporosis	0.000146	0.000499	CcSEcCtD
Etoricoxib—Dizziness—Ibandronate—osteoporosis	0.000146	0.000499	CcSEcCtD
Etoricoxib—Rash—Estropipate—osteoporosis	0.000145	0.000496	CcSEcCtD
Etoricoxib—Dermatitis—Estropipate—osteoporosis	0.000145	0.000496	CcSEcCtD
Etoricoxib—Anorexia—Conjugated Estrogens—osteoporosis	0.000145	0.000496	CcSEcCtD
Etoricoxib—Urticaria—Risedronate—osteoporosis	0.000144	0.000494	CcSEcCtD
Etoricoxib—Headache—Estropipate—osteoporosis	0.000144	0.000493	CcSEcCtD
Etoricoxib—Vomiting—Alendronate—osteoporosis	0.000144	0.000493	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000144	0.000492	CcSEcCtD
Etoricoxib—Abdominal pain—Risedronate—osteoporosis	0.000144	0.000492	CcSEcCtD
Etoricoxib—Muscle spasms—Estradiol—osteoporosis	0.000143	0.00049	CcSEcCtD
Etoricoxib—Rash—Alendronate—osteoporosis	0.000143	0.000489	CcSEcCtD
Etoricoxib—Insomnia—Zoledronate—osteoporosis	0.000143	0.000488	CcSEcCtD
Etoricoxib—Dermatitis—Alendronate—osteoporosis	0.000143	0.000488	CcSEcCtD
Etoricoxib—Feeling abnormal—Pamidronate—osteoporosis	0.000142	0.000487	CcSEcCtD
Etoricoxib—Headache—Alendronate—osteoporosis	0.000142	0.000486	CcSEcCtD
Etoricoxib—Vomiting—Raloxifene—osteoporosis	0.000142	0.000485	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Pamidronate—osteoporosis	0.000141	0.000483	CcSEcCtD
Etoricoxib—Dyspnoea—Zoledronate—osteoporosis	0.000141	0.000481	CcSEcCtD
Etoricoxib—Rash—Raloxifene—osteoporosis	0.000141	0.000481	CcSEcCtD
Etoricoxib—Dermatitis—Raloxifene—osteoporosis	0.00014	0.00048	CcSEcCtD
Etoricoxib—Somnolence—Zoledronate—osteoporosis	0.00014	0.00048	CcSEcCtD
Etoricoxib—Vomiting—Ibandronate—osteoporosis	0.00014	0.00048	CcSEcCtD
Etoricoxib—Tremor—Estradiol—osteoporosis	0.00014	0.000478	CcSEcCtD
Etoricoxib—Headache—Raloxifene—osteoporosis	0.00014	0.000477	CcSEcCtD
Etoricoxib—Rash—Ibandronate—osteoporosis	0.000139	0.000476	CcSEcCtD
Etoricoxib—Dermatitis—Ibandronate—osteoporosis	0.000139	0.000475	CcSEcCtD
Etoricoxib—Dyspepsia—Zoledronate—osteoporosis	0.000139	0.000475	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000139	0.000474	CcSEcCtD
Etoricoxib—Headache—Ibandronate—osteoporosis	0.000138	0.000473	CcSEcCtD
Etoricoxib—Insomnia—Conjugated Estrogens—osteoporosis	0.000138	0.00047	CcSEcCtD
Etoricoxib—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000137	0.00047	CcSEcCtD
Etoricoxib—Vomiting—Calcitriol—osteoporosis	0.000137	0.00047	CcSEcCtD
Etoricoxib—Decreased appetite—Zoledronate—osteoporosis	0.000137	0.000469	CcSEcCtD
Etoricoxib—Agitation—Estradiol—osteoporosis	0.000137	0.000469	CcSEcCtD
Etoricoxib—Nausea—Estropipate—osteoporosis	0.000137	0.000467	CcSEcCtD
Etoricoxib—Abdominal pain—Pamidronate—osteoporosis	0.000137	0.000467	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000136	0.000466	CcSEcCtD
Etoricoxib—Angioedema—Estradiol—osteoporosis	0.000136	0.000466	CcSEcCtD
Etoricoxib—Rash—Calcitriol—osteoporosis	0.000136	0.000466	CcSEcCtD
Etoricoxib—Fatigue—Zoledronate—osteoporosis	0.000136	0.000466	CcSEcCtD
Etoricoxib—Dermatitis—Calcitriol—osteoporosis	0.000136	0.000465	CcSEcCtD
Etoricoxib—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000136	0.000464	CcSEcCtD
Etoricoxib—Headache—Calcitriol—osteoporosis	0.000135	0.000463	CcSEcCtD
Etoricoxib—Somnolence—Conjugated Estrogens—osteoporosis	0.000135	0.000462	CcSEcCtD
Etoricoxib—Pain—Zoledronate—osteoporosis	0.000135	0.000462	CcSEcCtD
Etoricoxib—Constipation—Zoledronate—osteoporosis	0.000135	0.000462	CcSEcCtD
Etoricoxib—Nausea—Alendronate—osteoporosis	0.000135	0.00046	CcSEcCtD
Etoricoxib—Hypersensitivity—Risedronate—osteoporosis	0.000134	0.000458	CcSEcCtD
Etoricoxib—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000134	0.000458	CcSEcCtD
Etoricoxib—Asthenia—Ethinyl Estradiol—osteoporosis	0.000134	0.000458	CcSEcCtD
Etoricoxib—Nausea—Raloxifene—osteoporosis	0.000132	0.000453	CcSEcCtD
Etoricoxib—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000132	0.000452	CcSEcCtD
Etoricoxib—Pruritus—Ethinyl Estradiol—osteoporosis	0.000132	0.000451	CcSEcCtD
Etoricoxib—Palpitations—Estradiol—osteoporosis	0.000132	0.000451	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000131	0.000449	CcSEcCtD
Etoricoxib—Fatigue—Conjugated Estrogens—osteoporosis	0.000131	0.000448	CcSEcCtD
Etoricoxib—Nausea—Ibandronate—osteoporosis	0.000131	0.000448	CcSEcCtD
Etoricoxib—Asthenia—Risedronate—osteoporosis	0.00013	0.000446	CcSEcCtD
Etoricoxib—Feeling abnormal—Zoledronate—osteoporosis	0.00013	0.000445	CcSEcCtD
Etoricoxib—Cough—Estradiol—osteoporosis	0.00013	0.000445	CcSEcCtD
Etoricoxib—Pain—Conjugated Estrogens—osteoporosis	0.00013	0.000445	CcSEcCtD
Etoricoxib—Constipation—Conjugated Estrogens—osteoporosis	0.00013	0.000445	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Zoledronate—osteoporosis	0.000129	0.000442	CcSEcCtD
Etoricoxib—Hypertension—Estradiol—osteoporosis	0.000129	0.00044	CcSEcCtD
Etoricoxib—Pruritus—Risedronate—osteoporosis	0.000129	0.00044	CcSEcCtD
Etoricoxib—Nausea—Calcitriol—osteoporosis	0.000128	0.000439	CcSEcCtD
Etoricoxib—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000128	0.000436	CcSEcCtD
Etoricoxib—Hypersensitivity—Pamidronate—osteoporosis	0.000127	0.000436	CcSEcCtD
Etoricoxib—Arthralgia—Estradiol—osteoporosis	0.000127	0.000434	CcSEcCtD
Etoricoxib—Chest pain—Estradiol—osteoporosis	0.000127	0.000434	CcSEcCtD
Etoricoxib—Anxiety—Estradiol—osteoporosis	0.000127	0.000433	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000126	0.000431	CcSEcCtD
Etoricoxib—Urticaria—Zoledronate—osteoporosis	0.000125	0.000429	CcSEcCtD
Etoricoxib—Abdominal pain—Zoledronate—osteoporosis	0.000125	0.000427	CcSEcCtD
Etoricoxib—Diarrhoea—Risedronate—osteoporosis	0.000124	0.000425	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000124	0.000425	CcSEcCtD
Etoricoxib—Dry mouth—Estradiol—osteoporosis	0.000124	0.000425	CcSEcCtD
Etoricoxib—Asthenia—Pamidronate—osteoporosis	0.000124	0.000424	CcSEcCtD
Etoricoxib—Dizziness—Ethinyl Estradiol—osteoporosis	0.000123	0.000422	CcSEcCtD
Etoricoxib—Confusional state—Estradiol—osteoporosis	0.000123	0.00042	CcSEcCtD
Etoricoxib—Pruritus—Pamidronate—osteoporosis	0.000122	0.000418	CcSEcCtD
Etoricoxib—Oedema—Estradiol—osteoporosis	0.000122	0.000416	CcSEcCtD
Etoricoxib—Anaphylactic shock—Estradiol—osteoporosis	0.000122	0.000416	CcSEcCtD
Etoricoxib—Infection—Estradiol—osteoporosis	0.000121	0.000413	CcSEcCtD
Etoricoxib—Urticaria—Conjugated Estrogens—osteoporosis	0.000121	0.000413	CcSEcCtD
Etoricoxib—Dizziness—Risedronate—osteoporosis	0.00012	0.000411	CcSEcCtD
Etoricoxib—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00012	0.000411	CcSEcCtD
Etoricoxib—Shock—Estradiol—osteoporosis	0.00012	0.000409	CcSEcCtD
Etoricoxib—Nervous system disorder—Estradiol—osteoporosis	0.000119	0.000408	CcSEcCtD
Etoricoxib—Vomiting—Ethinyl Estradiol—osteoporosis	0.000119	0.000406	CcSEcCtD
Etoricoxib—Diarrhoea—Pamidronate—osteoporosis	0.000118	0.000404	CcSEcCtD
Etoricoxib—Skin disorder—Estradiol—osteoporosis	0.000118	0.000404	CcSEcCtD
Etoricoxib—Rash—Ethinyl Estradiol—osteoporosis	0.000118	0.000402	CcSEcCtD
Etoricoxib—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000117	0.000402	CcSEcCtD
Etoricoxib—Headache—Ethinyl Estradiol—osteoporosis	0.000117	0.0004	CcSEcCtD
Etoricoxib—Hypersensitivity—Zoledronate—osteoporosis	0.000116	0.000398	CcSEcCtD
Etoricoxib—Vomiting—Risedronate—osteoporosis	0.000116	0.000395	CcSEcCtD
Etoricoxib—Rash—Risedronate—osteoporosis	0.000115	0.000392	CcSEcCtD
Etoricoxib—Dermatitis—Risedronate—osteoporosis	0.000115	0.000392	CcSEcCtD
Etoricoxib—Dizziness—Pamidronate—osteoporosis	0.000114	0.000391	CcSEcCtD
Etoricoxib—Headache—Risedronate—osteoporosis	0.000114	0.00039	CcSEcCtD
Etoricoxib—Asthenia—Zoledronate—osteoporosis	0.000113	0.000387	CcSEcCtD
Etoricoxib—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000112	0.000383	CcSEcCtD
Etoricoxib—Pruritus—Zoledronate—osteoporosis	0.000112	0.000382	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000111	0.000379	CcSEcCtD
Etoricoxib—Nausea—Ethinyl Estradiol—osteoporosis	0.000111	0.000379	CcSEcCtD
Etoricoxib—Insomnia—Estradiol—osteoporosis	0.00011	0.000376	CcSEcCtD
Etoricoxib—Vomiting—Pamidronate—osteoporosis	0.00011	0.000376	CcSEcCtD
Etoricoxib—Asthenia—Conjugated Estrogens—osteoporosis	0.000109	0.000373	CcSEcCtD
Etoricoxib—Rash—Pamidronate—osteoporosis	0.000109	0.000373	CcSEcCtD
Etoricoxib—Dermatitis—Pamidronate—osteoporosis	0.000109	0.000372	CcSEcCtD
Etoricoxib—Dyspnoea—Estradiol—osteoporosis	0.000108	0.000371	CcSEcCtD
Etoricoxib—Headache—Pamidronate—osteoporosis	0.000108	0.00037	CcSEcCtD
Etoricoxib—Somnolence—Estradiol—osteoporosis	0.000108	0.00037	CcSEcCtD
Etoricoxib—Diarrhoea—Zoledronate—osteoporosis	0.000108	0.000369	CcSEcCtD
Etoricoxib—Nausea—Risedronate—osteoporosis	0.000108	0.000369	CcSEcCtD
Etoricoxib—Pruritus—Conjugated Estrogens—osteoporosis	0.000108	0.000368	CcSEcCtD
Etoricoxib—Dyspepsia—Estradiol—osteoporosis	0.000107	0.000366	CcSEcCtD
Etoricoxib—Decreased appetite—Estradiol—osteoporosis	0.000106	0.000362	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Estradiol—osteoporosis	0.000105	0.000359	CcSEcCtD
Etoricoxib—Fatigue—Estradiol—osteoporosis	0.000105	0.000359	CcSEcCtD
Etoricoxib—Dizziness—Zoledronate—osteoporosis	0.000104	0.000357	CcSEcCtD
Etoricoxib—Pain—Estradiol—osteoporosis	0.000104	0.000356	CcSEcCtD
Etoricoxib—Constipation—Estradiol—osteoporosis	0.000104	0.000356	CcSEcCtD
Etoricoxib—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000104	0.000356	CcSEcCtD
Etoricoxib—Nausea—Pamidronate—osteoporosis	0.000103	0.000351	CcSEcCtD
Etoricoxib—Dizziness—Conjugated Estrogens—osteoporosis	0.000101	0.000344	CcSEcCtD
Etoricoxib—Vomiting—Zoledronate—osteoporosis	0.0001	0.000343	CcSEcCtD
Etoricoxib—Feeling abnormal—Estradiol—osteoporosis	0.0001	0.000343	CcSEcCtD
Etoricoxib—Rash—Zoledronate—osteoporosis	9.96e-05	0.00034	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Estradiol—osteoporosis	9.95e-05	0.00034	CcSEcCtD
Etoricoxib—Dermatitis—Zoledronate—osteoporosis	9.95e-05	0.00034	CcSEcCtD
Etoricoxib—Headache—Zoledronate—osteoporosis	9.89e-05	0.000338	CcSEcCtD
Etoricoxib—Vomiting—Conjugated Estrogens—osteoporosis	9.67e-05	0.000331	CcSEcCtD
Etoricoxib—Urticaria—Estradiol—osteoporosis	9.67e-05	0.000331	CcSEcCtD
Etoricoxib—Abdominal pain—Estradiol—osteoporosis	9.62e-05	0.000329	CcSEcCtD
Etoricoxib—Rash—Conjugated Estrogens—osteoporosis	9.59e-05	0.000328	CcSEcCtD
Etoricoxib—Dermatitis—Conjugated Estrogens—osteoporosis	9.58e-05	0.000328	CcSEcCtD
Etoricoxib—Headache—Conjugated Estrogens—osteoporosis	9.53e-05	0.000326	CcSEcCtD
Etoricoxib—Nausea—Zoledronate—osteoporosis	9.38e-05	0.000321	CcSEcCtD
Etoricoxib—Nausea—Conjugated Estrogens—osteoporosis	9.03e-05	0.000309	CcSEcCtD
Etoricoxib—Hypersensitivity—Estradiol—osteoporosis	8.97e-05	0.000307	CcSEcCtD
Etoricoxib—Asthenia—Estradiol—osteoporosis	8.73e-05	0.000299	CcSEcCtD
Etoricoxib—Pruritus—Estradiol—osteoporosis	8.61e-05	0.000294	CcSEcCtD
Etoricoxib—Diarrhoea—Estradiol—osteoporosis	8.33e-05	0.000285	CcSEcCtD
Etoricoxib—Dizziness—Estradiol—osteoporosis	8.05e-05	0.000275	CcSEcCtD
Etoricoxib—Vomiting—Estradiol—osteoporosis	7.74e-05	0.000265	CcSEcCtD
Etoricoxib—Rash—Estradiol—osteoporosis	7.67e-05	0.000262	CcSEcCtD
Etoricoxib—Dermatitis—Estradiol—osteoporosis	7.67e-05	0.000262	CcSEcCtD
Etoricoxib—Headache—Estradiol—osteoporosis	7.62e-05	0.000261	CcSEcCtD
Etoricoxib—Nausea—Estradiol—osteoporosis	7.23e-05	0.000247	CcSEcCtD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.44e-05	0.00043	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—FDPS—osteoporosis	4.42e-05	0.000428	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PKM—osteoporosis	4.42e-05	0.000428	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.42e-05	0.000427	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MGLL—osteoporosis	4.37e-05	0.000423	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—POMC—osteoporosis	4.31e-05	0.000417	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—POMC—osteoporosis	4.27e-05	0.000413	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6R—osteoporosis	4.24e-05	0.00041	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CA2—osteoporosis	4.22e-05	0.000409	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—OXCT1—osteoporosis	4.22e-05	0.000409	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PGLS—osteoporosis	4.19e-05	0.000405	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPD2—osteoporosis	4.19e-05	0.000405	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.12e-05	0.000399	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—osteoporosis	4.12e-05	0.000399	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MGLL—osteoporosis	4.12e-05	0.000398	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IGF1—osteoporosis	4.1e-05	0.000396	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR2—osteoporosis	4.07e-05	0.000394	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—FDPS—osteoporosis	4.07e-05	0.000393	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PKM—osteoporosis	4.07e-05	0.000393	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ACP5—osteoporosis	4.06e-05	0.000393	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—FDPS—osteoporosis	4.03e-05	0.00039	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PKM—osteoporosis	4.03e-05	0.00039	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IRS1—osteoporosis	3.98e-05	0.000385	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—P4HB—osteoporosis	3.89e-05	0.000376	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KL—osteoporosis	3.88e-05	0.000375	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPD2—osteoporosis	3.85e-05	0.000373	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PGLS—osteoporosis	3.85e-05	0.000373	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ATIC—osteoporosis	3.83e-05	0.000371	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PNP—osteoporosis	3.83e-05	0.000371	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PGLS—osteoporosis	3.82e-05	0.00037	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPD2—osteoporosis	3.82e-05	0.00037	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.8e-05	0.000367	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—osteoporosis	3.79e-05	0.000367	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTH—osteoporosis	3.78e-05	0.000366	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.78e-05	0.000365	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TPI1—osteoporosis	3.78e-05	0.000365	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6R—osteoporosis	3.74e-05	0.000362	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RAP1A—osteoporosis	3.72e-05	0.00036	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—IDH2—osteoporosis	3.72e-05	0.00036	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CNR2—osteoporosis	3.69e-05	0.000357	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—POMC—osteoporosis	3.65e-05	0.000353	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFATC1—osteoporosis	3.63e-05	0.000351	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—DKK1—osteoporosis	3.6e-05	0.000348	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—P4HB—osteoporosis	3.55e-05	0.000343	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PNP—osteoporosis	3.53e-05	0.000341	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ATIC—osteoporosis	3.53e-05	0.000341	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—IDH2—osteoporosis	3.5e-05	0.000339	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP27A1—osteoporosis	3.5e-05	0.000338	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PNP—osteoporosis	3.49e-05	0.000338	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ATIC—osteoporosis	3.49e-05	0.000338	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GAPDH—osteoporosis	3.48e-05	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—WNT1—osteoporosis	3.47e-05	0.000335	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PKM—osteoporosis	3.44e-05	0.000333	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—FDPS—osteoporosis	3.44e-05	0.000333	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.43e-05	0.000332	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.42e-05	0.000331	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ACP5—osteoporosis	3.4e-05	0.000329	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGA—osteoporosis	3.37e-05	0.000326	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.36e-05	0.000325	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NFATC1—osteoporosis	3.31e-05	0.00032	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP27A1—osteoporosis	3.29e-05	0.000318	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—DKK1—osteoporosis	3.28e-05	0.000318	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPD2—osteoporosis	3.27e-05	0.000316	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PGLS—osteoporosis	3.27e-05	0.000316	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CA2—osteoporosis	3.26e-05	0.000315	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—OXCT1—osteoporosis	3.26e-05	0.000315	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—VDR—osteoporosis	3.23e-05	0.000312	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ACP5—osteoporosis	3.2e-05	0.00031	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.2e-05	0.000309	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MGLL—osteoporosis	3.18e-05	0.000307	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—WNT1—osteoporosis	3.16e-05	0.000306	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TPI1—osteoporosis	3.16e-05	0.000306	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTHLH—osteoporosis	3.14e-05	0.000303	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BMP2—osteoporosis	3.14e-05	0.000303	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—osteoporosis	3.12e-05	0.000301	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGA—osteoporosis	3.08e-05	0.000298	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGB—osteoporosis	3.07e-05	0.000297	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AGER—osteoporosis	3.05e-05	0.000295	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ADCY5—osteoporosis	3.04e-05	0.000294	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—OXCT1—osteoporosis	3e-05	0.00029	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CA2—osteoporosis	3e-05	0.00029	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.99e-05	0.00029	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ATIC—osteoporosis	2.99e-05	0.000289	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PNP—osteoporosis	2.99e-05	0.000289	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TPI1—osteoporosis	2.98e-05	0.000288	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—P4HB—osteoporosis	2.97e-05	0.000287	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CA2—osteoporosis	2.97e-05	0.000287	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—OXCT1—osteoporosis	2.97e-05	0.000287	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PSMA5—osteoporosis	2.96e-05	0.000287	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PSMA2—osteoporosis	2.96e-05	0.000287	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—osteoporosis	2.92e-05	0.000283	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MGLL—osteoporosis	2.92e-05	0.000282	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GAPDH—osteoporosis	2.92e-05	0.000282	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MGLL—osteoporosis	2.9e-05	0.00028	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RAP1A—osteoporosis	2.84e-05	0.000275	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—POMC—osteoporosis	2.82e-05	0.000273	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—P4HB—osteoporosis	2.8e-05	0.000271	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CALCA—osteoporosis	2.76e-05	0.000267	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GAPDH—osteoporosis	2.75e-05	0.000266	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ENO1—osteoporosis	2.74e-05	0.000265	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.73e-05	0.000264	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PSMA2—osteoporosis	2.7e-05	0.000261	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PSMA5—osteoporosis	2.7e-05	0.000261	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—IDH2—osteoporosis	2.7e-05	0.000261	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RAP1A—osteoporosis	2.68e-05	0.000259	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FDPS—osteoporosis	2.66e-05	0.000257	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PKM—osteoporosis	2.66e-05	0.000257	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRS2—osteoporosis	2.66e-05	0.000257	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—OXCT1—osteoporosis	2.54e-05	0.000246	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CA2—osteoporosis	2.54e-05	0.000246	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.54e-05	0.000246	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPD2—osteoporosis	2.52e-05	0.000244	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PGLS—osteoporosis	2.52e-05	0.000244	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CALCA—osteoporosis	2.52e-05	0.000244	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KL—osteoporosis	2.51e-05	0.000242	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—osteoporosis	2.5e-05	0.000242	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—IDH2—osteoporosis	2.48e-05	0.00024	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.48e-05	0.00024	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MGLL—osteoporosis	2.47e-05	0.000239	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ACP5—osteoporosis	2.47e-05	0.000239	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR1—osteoporosis	2.47e-05	0.000239	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—IDH2—osteoporosis	2.46e-05	0.000238	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—osteoporosis	2.46e-05	0.000238	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.44e-05	0.000236	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—osteoporosis	2.34e-05	0.000226	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.34e-05	0.000226	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.33e-05	0.000226	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRS1—osteoporosis	2.32e-05	0.000224	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.32e-05	0.000224	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PNP—osteoporosis	2.3e-05	0.000223	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ATIC—osteoporosis	2.3e-05	0.000223	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ENO1—osteoporosis	2.3e-05	0.000222	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TPI1—osteoporosis	2.3e-05	0.000222	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KL—osteoporosis	2.29e-05	0.000221	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ACP5—osteoporosis	2.27e-05	0.00022	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PSMA2—osteoporosis	2.26e-05	0.000219	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PSMA5—osteoporosis	2.26e-05	0.000219	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ACP5—osteoporosis	2.25e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.22e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6R—osteoporosis	2.18e-05	0.000211	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ENO1—osteoporosis	2.16e-05	0.000209	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—P4HB—osteoporosis	2.16e-05	0.000209	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PSMA2—osteoporosis	2.13e-05	0.000206	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PSMA5—osteoporosis	2.13e-05	0.000206	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GAPDH—osteoporosis	2.12e-05	0.000205	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TPI1—osteoporosis	2.11e-05	0.000204	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—IDH2—osteoporosis	2.1e-05	0.000203	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TPI1—osteoporosis	2.09e-05	0.000202	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RAP1A—osteoporosis	2.06e-05	0.0002	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—P4HB—osteoporosis	1.99e-05	0.000192	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.98e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—P4HB—osteoporosis	1.97e-05	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADCY5—osteoporosis	1.96e-05	0.00019	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—OXCT1—osteoporosis	1.96e-05	0.00019	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CA2—osteoporosis	1.96e-05	0.00019	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GAPDH—osteoporosis	1.95e-05	0.000188	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GAPDH—osteoporosis	1.93e-05	0.000187	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ACP5—osteoporosis	1.92e-05	0.000186	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MGLL—osteoporosis	1.91e-05	0.000185	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.9e-05	0.000184	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SPP1—osteoporosis	1.9e-05	0.000184	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RAP1A—osteoporosis	1.9e-05	0.000184	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—osteoporosis	1.89e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RAP1A—osteoporosis	1.88e-05	0.000182	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP19A1—osteoporosis	1.84e-05	0.000178	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.8e-05	0.000174	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ADCY5—osteoporosis	1.79e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TPI1—osteoporosis	1.79e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.73e-05	0.000167	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IRS2—osteoporosis	1.72e-05	0.000166	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—P4HB—osteoporosis	1.68e-05	0.000163	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LEP—osteoporosis	1.68e-05	0.000163	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ENO1—osteoporosis	1.67e-05	0.000161	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—osteoporosis	1.67e-05	0.000161	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—osteoporosis	1.66e-05	0.00016	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GAPDH—osteoporosis	1.65e-05	0.00016	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—osteoporosis	1.65e-05	0.000159	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PSMA2—osteoporosis	1.64e-05	0.000159	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PSMA5—osteoporosis	1.64e-05	0.000159	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.64e-05	0.000159	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—IDH2—osteoporosis	1.62e-05	0.000157	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RAP1A—osteoporosis	1.61e-05	0.000156	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ESR1—osteoporosis	1.61e-05	0.000155	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS2—osteoporosis	1.57e-05	0.000152	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ENO1—osteoporosis	1.53e-05	0.000148	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000148	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ENO1—osteoporosis	1.52e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000146	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000146	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ADCY5—osteoporosis	1.5e-05	0.000145	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IRS1—osteoporosis	1.5e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PSMA2—osteoporosis	1.5e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PSMA5—osteoporosis	1.5e-05	0.000145	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GPX1—osteoporosis	1.5e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ACP5—osteoporosis	1.49e-05	0.000144	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—osteoporosis	1.44e-05	0.00014	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000137	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6R—osteoporosis	1.41e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPX1—osteoporosis	1.41e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.4e-05	0.000136	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—osteoporosis	1.39e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TPI1—osteoporosis	1.38e-05	0.000134	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—osteoporosis	1.38e-05	0.000133	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS1—osteoporosis	1.37e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.33e-05	0.000129	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ENO1—osteoporosis	1.3e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—osteoporosis	1.3e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—P4HB—osteoporosis	1.3e-05	0.000126	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6R—osteoporosis	1.29e-05	0.000124	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—osteoporosis	1.28e-05	0.000124	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PSMA5—osteoporosis	1.28e-05	0.000124	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PSMA2—osteoporosis	1.28e-05	0.000124	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RAP1A—osteoporosis	1.24e-05	0.00012	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.23e-05	0.000119	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000118	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—osteoporosis	1.1e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000105	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX1—osteoporosis	1.09e-05	0.000105	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.04e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—osteoporosis	1.04e-05	0.0001	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO1—osteoporosis	1e-05	9.7e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ADCY5—osteoporosis	1e-05	9.69e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—osteoporosis	1e-05	9.69e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX1—osteoporosis	9.99e-06	9.66e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ADCY5—osteoporosis	9.94e-06	9.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX1—osteoporosis	9.9e-06	9.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PSMA2—osteoporosis	9.89e-06	9.56e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PSMA5—osteoporosis	9.89e-06	9.56e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—osteoporosis	9.71e-06	9.39e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—osteoporosis	9.22e-06	8.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—osteoporosis	9.14e-06	8.84e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADCY5—osteoporosis	8.49e-06	8.21e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX1—osteoporosis	8.46e-06	8.18e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—osteoporosis	8.35e-06	8.08e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—osteoporosis	8.33e-06	8.06e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.02e-06	7.76e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—osteoporosis	8.02e-06	7.75e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—osteoporosis	7.81e-06	7.55e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—osteoporosis	7.62e-06	7.37e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—osteoporosis	7.6e-06	7.35e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—osteoporosis	7.37e-06	7.13e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—osteoporosis	7.31e-06	7.07e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADCY5—osteoporosis	6.55e-06	6.34e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX1—osteoporosis	6.53e-06	6.32e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—osteoporosis	6.28e-06	6.07e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—osteoporosis	6.25e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—osteoporosis	6.03e-06	5.83e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—osteoporosis	5.73e-06	5.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—osteoporosis	4.82e-06	4.66e-05	CbGpPWpGaD
